By Amy Siegel, S2N Health
The CEOs of emerging med tech companies are among the hardest working people I know. There are a multitude of things to worry about, with several on the edge of cataclysm at any given point – keeping money in the bank, getting the damn technology to work, the FDA, building out the human and capital infrastructure, managing the burn rate, filing IP, gearing up clinical trials, manufacturing, commercialization, engaging KOLs, generating “buzz”, meeting with strategic partners, managing the BOD, and so on. Just writing that sentence exhausted me. For a new CEO of a small med tech company, all this can be quite overwhelming, so I turned to my road-tested CEO clients and friends and asked them a simple question:
What’s the single most important piece of advice you would give to someone about to start their first emerging med tech CEO job?
